Bibliography
Filters: Author is Dolezal, Tomas [Clear All Filters]
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract
Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):283-7. Abstract